✦ LIBER ✦

[Topics in Medicinal Chemistry] Cancer Volume 1 || Development of Angiogenesis Inhibitors to Vascular Endothelial Growth Factor Receptor 2 for Cancer Therapy

✍ Scribed by Bradbury, Robert H.

Book ID: 120646948
Publisher: Springer Berlin Heidelberg
Year: 2007
Weight: 503 KB
Category: Article
ISBN: 3540331204
DOI: 10.1007/7355_2006_009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vascular endothelial growth factor recep

Vascular endothelial growth factor receptor-1 in human cancer : Concise review and rationale for development of IMC-18F1 (Human antibody targeting vascular endothelial growth factor receptor-1)

✍ Jonathan D. Schwartz; Eric K. Rowinsky; Hagop Youssoufian; Bronislaw Pytowski; Y 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB

## Abstract The human vascular endothelial growth factor receptor‐1 (VEGFR‐1, or Flt‐1) is widely expressed in normal and pathologic tissue and contributes to the pathogenesis of both neoplastic and inflammatory diseases. In human cancer, VEGFR‐1 mediated signaling is responsible for both direct tu

Regulation of Hypoxia-Inducible Factor-1

Regulation of Hypoxia-Inducible Factor-1α, Vascular Endothelial Growth Factor, and Angiogenesis by an Insulin-Like Growth Factor-I Receptor Autocrine Loop in Human Pancreatic Cancer

✍ Oliver Stoeltzing; Wenbiao Liu; Niels Reinmuth; Fan Fan; Alexander A. Parikh; Co 📂 Article 📅 2003 🏛 American Society for Investigative Pathology 🌐 English ⚖ 861 KB

Transforming Growth Factor-β in Cancer T

Transforming Growth Factor-β in Cancer Therapy, Volume I || Topical Application of TGF-β1 Peptide Inhibitors for the Therapy of Skin Fibrosis

✍ Jakowlew, Sonia B. 📂 Article 📅 2008 🏛 Humana Press 🌐 English ⚖ 1009 KB

Transforming Growth Factor- ß In Cancer Therapy, Vols. 1 And 2, Provides A Compendium Of Findings About The Role Of Transforming Growth Factor- ß (tgf- ß) In Cancer Treatment And Therapy. The First Volume, Basic And Clinical Biology, Is Divided Into Three Parts. This Volume’s Companion, Cancer Treat

Biomarkers for assessment of pharmacolog

Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases

✍ Lucy Lee; Sunil Sharma; Bruno Morgan; Peter Allegrini; Christian Schnell; Josef 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 427 KB